INTRODUCTION
Campylobacteriosis is the most prevalent bacterial gastrointestinal disease in humans in the developed world with Campylobacter jejuni and C. coli being the most often identified causative species. The disease is usually self-limiting in humans but in certain circumstances, such as in severe cases or in immunocompromised patients, antimicrobial treatment is warranted. Then macrolides or fluoroquinolones are preferentially used. Intravenous aminoglycosides can also be used in serious bacteraemia (Aarestrup & Engberg, 2001 ).
In recent years, frequent occurrences of aminoglycoside resistant Campylobacter isolates of animal and human origin have been reported in several countries (Guevremont et al., 2006; Pezzotti et al., 2003; Qin et al., 2011; Torralbo et al., 2015; Zhang et al., 2014) , and in some studies, higher rates of streptomycin (STR) resistance have been detected in C. coli compared to C. jejuni (Giacomelli et al., 2014; Torralbo et al., 2015) . Several mechanisms of aminoglycoside resistance have been described in Gram-positive and Gram-negative bacteria with the most important ones being alterations at the ribosomal binding sites (Carter et al., 2000; Meier et al., 1996; Olkkola et al., 2010; Torii et al., 2003) and enzymatic drug modification (for review see Ramirez & Tolmasky, 2010) . Genes encoding aminoglycoside modification enzymes have been commonly detected in Campylobacter species (Abril et al., 2010; Chen et al., 2013; Nirdnoy et al., 2005; Qin et al., 2012) .
Aminoglycoside antibiotics can be inactivated by three groups of modifying enzymes, O-phosphotransferases (APH), N-acetyltransferases (AAC) and O-nucleotidyl/ adenylyltransferases (ANT) each enzyme having its own target drugs (Ramirez & Tolmasky, 2010; Shaw et al., 1993) . The ANT group is divided into five classes, ANT(2''), ANT (3''), ANT(4'), ANT(6) and ANT(9) , based on the position of adenylylation in the target drug. The ANT(6) and ANT (3'') classes of enzymes are known to confer resistance to STR only [ANT(6)] or to STR and spectinomycin (SPEC) [ANT(3'') ]. Genes in the ANT(6) class [known as ant(6), aadE or aadK] are quite divergent and very common among Gram-positive bacteria (for review see Ramirez & Tolmasky, 2010; Vakulenko & Mobashery, 2003) . The ant (6) genes found in Campylobacter spp. have often been similar to those from Gram-positive bacterial species and located in transposons, integrons or multiple drug resistance (MDR) plasmids with other resistance genes such as in resistance gene triplet aadE-sat4-aphA3 and/or tetracycline resistance gene tetO (Abril et al., 2010; Chen et al., 2013; Nirdnoy et al., 2005; O'Connor et al., 2007; Qin et al., 2012) .
In a previous study, we discovered that specific mutations in the ribosomal protein S12 encoding gene rpsL conferred high levels of STR resistance (MIC>1024 mg l À1 ) in C. coli originating from a Finnish swine farm . However, we were unable to determine the resistance mechanism of isolates with MIC values ranging between 128 and 512 mg l À1 (defined as intermediately STR resistant isolates). These isolates neither showed any apparent modification of the ribosomal binding sites nor did they harbour genes associated with STR resistance . Therefore, in the present study, we applied a whole genome sequencing approach with the aim to identify potential genetic features associated with intermediate-level STR resistance phenotype in C. coli.
METHODS
Bacterial isolates, culture conditions, reagents and MIC testing. The 46 C. coli isolates included in this study originated from pigs reared on three Finnish farms (I-III). At farm III, a fluoroquinolone (danofloxacin) and a macrolide (tylosin) were used for part or for all of the animals, respectively (Juntunen et al., 2011) . The medications of the piglets, fecal sampling, isolation and PFGE typing of the C. coli isolates from the other farms, have been described previously (Juntunen et al., , 2011 Olkkola et al., 2010) . For this study C. coli strains were routinely grown in nutrient agar with 5 % bovine blood (NBA) at 37 C under microaerobic conditions (5 % oxygen, 10 % carbon dioxide, 85 % nitrogen), unless otherwise stated. E. coli NEB 5-alpha (New England Biolabs) were grown on Luria-Bertani (LB) agar plates or LB broth (with shaking at 200 rpm) supplemented with ampicillin (100 µg ml À1 ) or chloramphenicol (33 µg ml
À1
) as appropriate and incubated at 37 C. Genomic DNA was isolated using either Wizard Genomic DNA Purification Kit (Promega) or Purelink Genomic DNA mini kit (Invitrogen) according to manufacturers' instructions. Primers used in this study are listed in Table 1 .
PCRs were performed using High-fidelity Phusion Hot Start DNA Polymerase (Thermo-Fischer Scientific). Vector pUC119 was selected as a backbone for the suicide plasmid used in the mutational analyses. The MICs were tested for STR, SPEC, ciprofloxacin and erythromycin using the agar dilution method (Clinical and Laboratory Standards Institute M31-A3). C. jejuni ATCC 33560 was used as a control in each assay.
Whole genome sequencing, annotation and data analysis.
Whole genome sequencing of 12 C. coli strains, all originating from farm III, selected based on their STR MICs, was performed using Illumina HiSeq technology and Nextera XT library paired-end kit (Institute for Molecular Medicine Finland FIMM Technology Centre, University of Helsinki, Finland). The paired-end reads were assembled into contigs with SPAdes 3.2.0 (Bankevich et al., 2012) , ensuring to run mismatch correction (flag-careful). MLST types were assigned with the Campylobacter MLST database and new C. coli allele sequences were submitted to the Campylobacter jejuni/coli MLST database (http://pubmlst.org/campylobacter/). Genomes were annotated in RAST (Aziz et al., 2008) . Whole genome multilocus sequence typing (wgMLST) analyses were performed with Genome Profiler (GeP) (Zhang et al., 2015) using default settings.
Screening for novel Campylobacter ant-like gene A and evolutionary analysis. Based on the nucleotide sequence of the detected Campylobacter ant-like gene A in C. coli 47.4 (peg 1084), primers CcoliaadE-Fw and CcoliaadE-Rw were designed (Table 1) . A total of 34 additional C. coli isolates from three Finnish pig farms: I (n=6), , II (n=11) and III (n=17) (Juntunen et al., 2011) with STR MICs ranging from 4 to >1024 mg l
were screened by PCR for the presence of the gene. The PCR conditions were as follows: initial activation for 2 min at 95 C, followed by 30 cycles of 30 s denaturation at 95 C, annealing for 30 s at 57 C and extension for 45 s at 72 C and final extension of 7 min at 72 C.
In addition, orthologues of peg 1084 of C. coli 47.4 were searched in silico in the whole genome sequences of~500 Finnish C. jejuni isolates originating from multiple sources (Kovanen et al., 2014; Llarena et al., 2014 using 40 % cut-off of the BLAST score ratio (Rasko et al., 2005) .
For evolutionary analysis, 130 homologous sequences were retrieved from NCBI nr database using blastx (http://blast.ncbi.nlm.nih.gov) with the nucleotide sequence of peg 1084 of C. coli 47.4. Amino acid sequences were aligned using MAFFT (Katoh et al., 2002) , and the evolutionary history was inferred in MEGA5.3 (Tamura et al., 2011) using the Minimum Evolution method (Rzhetsky & Nei, 1992) . The consensus tree was condensed using 95 % bootstrap values and edited in iTOL web server (Letunic & Bork, 2011) . Linear comparison of the genomic areas around the novel STR resistance gene also containing the donor and recipient strains in the natural transformation experiments was generated in Easyfig (Sullivan et al., 2011) .
Structural modelling of the novel Campylobacter ANT-like protein.
Structural models of the Campylobacter ANT-like proteins were built, based on the sequence alignments of C. coli 47.4 peg 1084 (Campylobacter ANT-like protein A) and C. jejuni 12xb_914 peg 678 (Campylobacter ANT-like protein B), using intensive mode implemented in the fully automated PHYRE2 server (Kelley & Sternberg, 2009; Kelley et al., 2015) . Model quality assessment, alignment confidence, catalytic site detection and conservation analysis using the aminoglycoside 6-nucleotidyltransferase from B. subtilis as reference structure were performed using Phyre2 investigator (Kelley et al., 2015) . Models were visualized using JSmol (Hanson et al., 2013) .
Expression of Campylobacter ant-like gene A and B in E. coli.
The Campylobacter ant-like genes A and B were amplified from C. coli 47.4 (peg 1084) and C. jejuni FB01514 (peg 240) with primers aadE-A-AF-KpnI and aadE-A-AR-PstI or ant60-A-AF-KpnI and ant60-A-ARPstI, respectively (Table 1) and cloned into pUC119 (pUC119antA or pUC119antB). Chemically competent E. coli NEB 5-alpha cells (New England Biolabs) were transformed with these plasmids. Transformants were confirmed by PCR or restriction. Selected transformant colonies were then tested for STR susceptibility by broth dilution (CLSI M07-A9).
Construction of 47.4DantA :: CAT mutant. Campylobacter ant-like gene A (C. coli 47.4 peg 1084) was interrupted by homologous recombination with chloramphenicol acetyltransferase cassette (CAT) as previously described (van Vliet et al., 1998) . Isolated pUC119-antA was used as a template for inverse PCR using primers aadE-A-IF-BamHI and aadE-A-IR-SalI (Table 1 ). The CAT cassette was ligated to the inverse PCR product to obtain pUC119DantA :: CAT, which was used as a suicide plasmid in C. coli 47.4. Electrocompetent C. coli 47.4 cells were prepared and transformed as described before (Miller et al., 1988) . Approximately 10 8 bacterial cells were mixed with 80 ng of purified pUC119DantA :: CAT, electroporated (2.5 kV) and left to recover overnight on NBA. Mutants were selected on NBA supplemented with 12.5 µg ml À1 of chloramphenicol. Homologous recombination was verified by PCR.
Natural transformation experiments. The STR susceptible strain C. coli 18.3 was used as a recipient in the transformation experiments using a biphasic protocol as described before (Sheppard et al., 2014; Wang et al., 1993) with some modifications. Briefly, after O/N culture in 2 ml nutrient broth (Oxoid), the OD 600 of the STR susceptible recipient was adjusted to 0.2, and 500 µl of each recipient suspension was transferred to two test tubes containing 5 ml NBA with slanted surface. After 3 h of microaerobic incubation at 37 C, 2 µg (10 µl) of chromosomal DNA from C. coli donor strain 47.4 was added to the recipient. The same volume of peptone water was used to control for spontaneous mutations. Incubation was continued for 3 h at 37 C under Table 1 . Primers used in this study *Isolates originating from the same animals are indicated with the same superscript letter (in brackets). Isolates 18.3 and 47.4 were used as recipient and donor in the natural transformation studies, respectively. †Samplings: I, before weaning, II and III after weaning, IV and V after danofloxacin for part of the pigs, VI after tylosin for all pigs (Juntunen et al., 2011) .
‡PFGE: SmaI +/À Kpn (Juntunen et al., 2011) . §No. of features includes coding sequences (CDS), rRNA and tRNA encoding genes. microaerobic conditions. Suspensions were then inoculated on NBA containing 64 or 32 mg l À1 of STR in the first and second experiments, respectively. The STR MICs of selected transformants and spontaneous mutants were determined by the agar dilution method, and the presence of Campylobacter ant-like gene A from selected transformants was confirmed by PCR as described earlier. Two natural transformants (A+.1, A +.2) and a spontaneous mutant (A.2) were whole genome sequenced.
RESULTS

STR resistance mechanisms
The STR MICs, detected STR resistance conferring genes and mutations, PFGE and wgMLST types and relevant genomic information of the twelve whole genome sequenced C. coli isolates originating from farm III are shown in Table 2 . Seven of the twelve studied isolates had increased MICs for STR, with four being high-level (>1024 mg l À1 ) and three intermediate-level (MIC 256-512 mg l À1 ) resistant. Fig. 1 shows the NeighborNet network of the wgMLST analysis of these isolates based on a total of 1522 shared loci (average of 82 % of total genome). All high-level STR resistant isolates harboured the AAAfiAGA (K43fiR) mutation in rpsL and belonged to the same ST and PFGE types clustering closely together with only few allelic differences. The intermediately STR resistant isolates belonged to two different unrelated strains (over 1000 allelic differences), and no STR resistance conferring mutations in rpsL were found. Thus, we searched the three genomes for genes detected solely in these intermediately resistant isolates and identified a gene (Campylobacter ant-like gene A) encoding a 300-amino acid (aa) protein homologous to, but sharing only a low percentage of amino acid identity with, aminoglycoside 6-nucleotidyl-transferases. BLAST score ratios between Campylobacter ANT-like protein A and the previously described ANT(6) proteins in Campylobacter spp. and certain other species are listed in Table 3 , and range between 0.11 and 0.24. This novel gene has GC content of 28 % and is located chromosomally in a region delimited upstream by allophanate hydrolase operon and downstream by the arsenical resistance operon. This genomic area corresponds to the previously described hypervariable region 14 (HR14, restriction-modification locus; from Cj1543c to Cj1563c) in C. jejuni NCTC 11168 (Stabler et al., 2013; Taboada et al., 2004) . The comparison of this hypervariable genomic region of five C. coli isolates containing the ant-like gene A (n=3) or not (n=2) is shown in Fig. 2 . As in C. jejuni, the region is characterized by the presence of a Type I restriction/modification system. In addition, it contains a variable set of oxidoreductases, hydrolases, dehydrogenases and decarboxylases involved in the metabolism of amino acids, alcohols and other compounds. The novel Campylobacter ant-like gene A locates in the same region in all three intermediately STR resistant C. coli isolates, and we did not detect any other previously described antibiotic resistance genes in this area.
Screening for Campylobacter ant-like gene A and evolutionary analysis
Of the 34 additional C. coli screened by PCR, only the isolates with intermediate-level STR MICs (128-512 mg l À1 , n=10) yielded a positive result in PCR. In addition, 19 out of~500 in silico screened whole genome sequenced C. jejuni isolates from our collection were found to harbour a gene homologue encoding a product showing 60 % amino acid identity to the novel Campylobacter ANT-like protein A. Further, this homologue is located in a similar genomic region as in C. coli: four to seven genes downstream from the allophanate hydrolase operon. However, the gene, named Campylobacter ant-like gene B, was detected only in C. jejuni strains sensitive to STR with MICs ranging between 0.5-2 mg l
À1
. Although having a very low amino acid identity, both proteins resembled the structure of aminoglycoside 6-nucleotidyltransferase from B. subtilis (accession PDB: 2PBE) and lincosamide adenylyltransferase LinB from Entercoccus faecium (Morar et al., 2009 ) which consist of two domains connected through an extensive loop region: the N-terminal domain containing b-sheets flanked by ahelices and the C-terminal domain composed by a-helical bundle (Fig. S1 , available in the online Supplementary Material).
To elucidate the possible origins of the novel ant-like genes we performed a phylogenetic analysis including 130 closest blast hits retrieved from NCBI nr. The minimum evolutionary tree (Fig. 3) showed that the protein encoded by C. coli 47.4 ant-like gene A (peg 1084) is part of a monophyletic group (red clade) together with other homologous proteins from C. coli originating from several sources and countries. Its sister clade (shown in green) is composed of gene products similar to that of Campylobacter ant-like gene B. The previously described 6-nucleotidyl-transferases in Campylobacter spp. (Table 3 , violet clades in Fig. 3 ) belong to a separate polychotomous clade (blue-branched clade) together with homologous proteins originating from Gram-positive bacterial species.
Expression in E. coli and knock-out mutant constructs
Because the novel ANT-like proteins shared only low amino acid identity with the previously described 6-nucleotidyltransferases, we measured the STR MIC of E. coli NEB cells carrying a plasmid inserted with ant-like gene A or B to explore their ability to confer STR resistance. The genes were amplified from C. coli and C. jejuni, respectively, including the putative upstream promoter region. All the E. coli transformants carrying ant-like gene A (n=7) showed 4-to more than 8-fold (16fi64->128 mg l À1 ) increase in STR MICs as compared to E. coli containing the plasmid without the insert. In contrast, no differences in STR MICs were seen in E. coli carrying the ant-like gene B.
Furthermore, we investigated the MICs for STR of C. coli 47.4DantA :: CAT mutants (n=14). All the mutant C. coli colonies showed 64-fold decrease of STR MICs (256fi 4 mg l
À1
). Susceptibility to spectinomycin (n=4), ciprofloxacin (n=9) and erythromycin (n=9) was also studied in selected mutants, but no differences were observed as compared to the C. coli 47.4 wild-type.
Natural transformations
We proceeded by examining the ability of the Campylobacter ant-like gene A to be naturally transferred to a STR susceptible C. coli with different ST and CC but sharing sequence homology in the hypervariable region 14. We performed two independent experiments using two STR concentrations for selection: 64 mg/l (experiment I) and 32 mg/l (experiment II). A total of 2 and 113 natural transformants were obtained from experiments I and II, respectively. In addition, one and three spontaneous mutants were generated in the same experiments, respectively. The STR MICs of the selected transformants (n=9) ranged between 64 and 512 mg l À1 and they were positive for the presence of ant-like gene A by PCR, while all the spontaneous mutants (n=4) had STR MIC>1024 mg l À1 and did not harbour the gene.
The genomes of a spontaneous mutant (A.2, MIC STR>1024 mg/l) and two natural transformants (A+.1, MIC STR 256 mg l À1 and A+.2, MIC STR 64 mg/l) were sequenced and compared with the genomes of the donor (47.4) and recipient (18.3) strains using Genome Profiler. The spontaneous mutant was found to have an AAAfiACT mutation in codon 43 (K43T) of rpsL, but no resistance conferring mutations were found in the rpsL sequences of the transformants. Genomic changes observed in the HR14 of the transformants are listed in Table 4 . In both cases the transfer of the hypervariable region containing the ant-like gene A resulted in a novel allele of a gene annotated as putative sarcosine oxidase. Also several other genes missing from the recipient were observed to transfer from the donor to both transformants including, for example, NAD(P)H oxidoreductase and RecD-like DNA helicase YrrC. In addition to the modification in the HR14, the transformants showed several other genomic changes as a result of recombination (Table S1 , available in the online Supplementary Material).
DISCUSSION
We identified a novel STR resistance conferring gene in C. coli that resembles aminoglycoside 6-nucleotidyltransferase encoding genes. However, this gene, named Campylobacter ant-like A, is not a close homologue of any of the previously described aminoglycoside 6-nucleotidyl-transferases from which it also differs in several other aspects. First, it seems to be inherent to C. coli and does not cluster phylogenetically with those of Gram-positive bacterial species like most of the previously described aminoglycoside adenylyltransferase encoding genes in Campylobacter spp. (Abril et al., 2010; Chen et al., 2013; Nirdnoy et al., 2005; Qin et al., 2012) . Second, it is located in a chromosomal area Allophanate hydrolase subunits 1 and 2 Type I restriction-modi cation system subunits Arsenical resistance operon 100% 69% Fig. 2 . Comparison of the hypervariable region 14 in five C. coli isolates of which three harbour the novel Campylobacter antlike gene A but belong to two unrelated strains ( Fig. 1 ) and a Campynet isolate (CNET072, STR MIC 64 mg/l) harbouring the gene and originating from a Danish pig. Genes of interest are coloured as follows: dark green, allophanate hydrolase subunits 1 and 2; violet, Type I restriction/modification system subunits; dark blue, sarcosine oxidase; brown, NAD(P)H oxidoreductase YRKL; black, Campylobacter ant-like gene A; light blue, RecD-like DNA helicase YrrC; light green, dienelactone hydrolase; grey, oxidoreductase of aldo/keto reductase family, subgroup 1; yellow, arsenical resistance operon.
corresponding to the hypervariable region 14 defined as a restriction-modification locus in C. jejuni (Stabler et al., 2013; Taboada et al., 2004) . Third, it is not part of a resistance gene cluster in a transposon or a plasmid.
Interestingly, this novel ant-like gene A seems to be widely spread among C. coli populations as it is found in strains originating from both Europe and United States and from several unrelated hosts including humans and also from environmental sources. Although Campylobacter ant-like gene A does not belong to any known transferable element, in this study, we found evidence of its ability to be transferred by homologous recombination into a susceptible Campylobacter host having a different MLST type, showing that it is able to transfer between less related strains also as long as they share enough sequence similarity in the hypervariable region. We also demonstrated that the antlike gene A was able to confer resistance when expressed in another bacterial species. Comparative genomic analysis of two naturally transformed C. coli variants revealed that multiple genes were transferred along with Campylobacter antlike gene A in a homologous recombination event. As expected, the selection for one characteristic, in this case STR resistance, led to co-selection of several other parts of the genome by stochastic recombination events, including recombination of the close genomic region along with the resistance determinant.
In our previous study, we have shown that high-level STR resistance (>1024 mg l À1 ) in C. coli is conferred by mutations in rpsL encoding the ribosomal protein S12 . Also in this study, we observed mutations in Multiple entries: Z156 and Z163, chicken, Switzerland; 84-2, swine, USA; H6, human, Switzerland; BIGS001, environment, UK (Sheppard et al., 2013) ; BIGS0009, human, USA (Sheppard et al., 2013) . *Sheppard et al., (2013) . rpsL leading to K43R transition in ribosomal protein S12 in all four studied farm-derived highly STR resistant C. coli isolates, which further confirms our previous results . In addition, a spontaneous highly STR resistant C. coli mutant obtained from a natural transformation assay exhibited a point mutation leading to K43T transversion in S12. Both of these rpsL mutations have been associated with STR resistance in, for example, Escherichia coli and Mycobacterium tuberculosis (Finken et al., 1993; Funatsu & Wittmann, 1972) . Further, all highly STR resistant ribosomal mutants were of the same genotype and very distinct from those of the intermediately resistant isolates. In the highly STR resistant isolates, only few genetic differences were detected, indicating clonal spread of these isolates in a pig farm for some unknown reason since aminoglycosides were not used at the farm. However, fluoroquinolones and macrolides were used for part or for all of the animals, respectively and an increase in the number of STR resistant isolates was seen after fluoroquinolone treatment in the treated group (Juntunen et al., 2011) , (Figs. S2 and S3). We did not observe the ant-like gene A to confer fluoroquinolone resistance, and the observed increase in STR resistant isolates after fluoroquinolone treatment could be due to co-selection possibly mediated by yet uncharacterized epistatic interactions. The Campylobacter ant-like gene A was not observed in any of the highly STR resistant C. coli indicating that harbouring lower level resistance conferring gene does not seem to lead to the development of high-level STR resistance conferring mutations in rpsL.
The closest homologue of Campylobacter ant-like gene A (Campylobacter ant-like B) encoding a product with 60 % amino acid identity was detected in both C. jejuni and C. coli in a similar genomic location. However, we were not able to associate the presence of this homologue with STR resistance. Several reasons might explain the lack of resistant phenotype of the strains harbouring Campylobacter ant-like gene B. Mutations in the promoter region or post-translational modifications of the protein might alter its expression. Alternatively, ANT-like protein B might be a nucleotidylating enzyme having different substrate Peg a specificity with only low or no affinity for STR making it remnant/not STR resistance conferring ant(6)-gene homologue as also described in other bacterial species (Ounissi et al., 1990) .
The origin of these distant Campylobacter aminoglycoside 6-nucleotidyltransferase homologues remain obscure. Lowlevel homology is not unexpected between aminoglycoside modifying enzymes, which are known to be heterologous (Smith & Baker, 2002) . These resistance elements could have evolved in antibiotic-producing bacteria and been disseminated mainly through horizontal transfer in bacterial populations, or they could have arisen through convergent evolution in several species from genes originally encoding proteins with different functions and substrates and later evolved to become aminoglycoside resistance genes (Davies & Wright, 1997; Franklin & Clarke, 2001; Magnet & Blanchard, 2005; Shaw et al., 1993) . The work by Morar et al. (2009) suggests that bona fide resistance nucleotidyltransferase encoding genes most likely evolved through natural selection from nucleotide polymerases, defined as proto-resistance elements (Morar et al., 2009) . In our phylogenetic analysis, Campylobacter ANTlike protein A did not cluster with the previously described aminoglycoside 6-nucleotidyl-transferases from other species and its GC content is close to the average GC content of C. coli. Also, we did not find insertion elements or other resistance conferring genes in the region. Therefore, it is possible that ant-like gene A has originated from a common ancestral proto-resistance element in Campylobacter spp. possibly originally encoding a protein with a different function.
In conclusion, the use of whole genome sequencing allowed us to determine the mechanism of the intermediate level of STR resistance in C. coli revealing the presence of a novel STR resistance gene. The gene product shares only low amino acid identity with the previously described ANT(6) enzymes and it could have evolved to become a STR resistance gene in C. coli as we did not find evidence of a recent jump of this gene to Campylobacter spp. from another species. This gene was able to increase STR MIC also in E. coli and could, therefore, be used as a genetic marker in cloning studies.
